aibio
Financings ·
Eikon Therapeutics prices IPO of 21,177,600 shares at $18.00
The offering totals $381,196,800. The stock is approved to list on Nasdaq under EIKN, and proceeds to the company are $354,513,024 before expenses.
EIKN Eikon Therapeutics, Inc.
Eikon Therapeutics (EIKN) news EIKN IPO and offering news
Latest Eikon Therapeutics news
- Financings
Eikon Therapeutics files for IPO of common stock, seeks Nasdaq listing as EIKN
The Delaware company applied to list on the Nasdaq Global Market. The share count and price range are blank in the preliminary prospectus.
Questions about Eikon Therapeutics
When did Eikon Therapeutics go public?
Our latest story on this, dated Feb 5, 2026: "Eikon Therapeutics prices IPO of 21,177,600 shares at $18.00". The story links the filing or release it is based on. Read the story.
Has Eikon Therapeutics raised money recently?
Our latest story on this, dated Feb 5, 2026: "Eikon Therapeutics prices IPO of 21,177,600 shares at $18.00". The story links the filing or release it is based on. Read the story.
What is the ticker symbol of Eikon Therapeutics?
Eikon Therapeutics, Inc. trades under the ticker EIKN on NASDAQ.
Where is Eikon Therapeutics listed?
Eikon Therapeutics, Inc. is listed on NASDAQ.
What is the SEC CIK of Eikon Therapeutics?
The SEC Central Index Key (CIK) for Eikon Therapeutics, Inc. is 1861123. Its filings are on SEC EDGAR.
How many shares does Eikon Therapeutics have outstanding?
54,165,030 shares as of 2026-08-03, per the cover page of its 10-Q filed 2026-08-13.
Which country or territory is Eikon Therapeutics listed under?
Our directory records Eikon Therapeutics, Inc. under United States.
What does Eikon Therapeutics do?
Our directory classifies Eikon Therapeutics, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Eikon Therapeutics?
The ISIN recorded for Eikon Therapeutics, Inc. is US2825641036.
Does aibio.space cover Eikon Therapeutics?
aibio.space lists Eikon Therapeutics, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Eikon Therapeutics incorporated?
SEC records list its state or country of incorporation as DE.
What is the latest Eikon Therapeutics (EIKN) stock news?
Our latest story on Eikon Therapeutics, dated Feb 5, 2026: "Eikon Therapeutics prices IPO of 21,177,600 shares at $18.00". The offering totals $381,196,800. The stock is approved to list on Nasdaq under EIKN, and proceeds to the company are $354,513,024 before expenses. Source.
How long will Eikon Therapeutics's cash last?
From our story of Feb 5, 2026: The prospectus says its recurring losses and financial condition raise substantial doubt about its ability to continue as a going concern. Source.
Is Eikon Therapeutics a smaller reporting company?
SEC records list Eikon Therapeutics, Inc.'s filer category as: <br>Emerging growth company.
Where is Eikon Therapeutics headquartered?
SEC records list its business address as 230 HARRIET TUBMAN WAY, MILLBRAE, CA, 94030.
Investor discussion: Eikon Therapeutics
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
Stock chart
SEC filings and registration
- SEC name
- Eikon Therapeutics, Inc.
- CIK
- 1861123
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) (2836)
- US tickers
- EIKN (Nasdaq)
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- Filer category
- <br>Emerging growth company
- Business address
- 230 HARRIET TUBMAN WAY, MILLBRAE, CA, 94030
- Phone
- 341-777-0566
- Shares outstanding
- 54,165,030 as of 2026-08-03 (10-Q filed 2026-08-13)
Recent filings
Listing details
- Company
- Eikon Therapeutics, Inc.
- Ticker
- EIKN
- Listing
- NASDAQ
- Country or territory
- United States
- Business scope
- Pharmaceuticals: Major
- ISIN
- US2825641036
- Last quote in directory
- 2026-10-21
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction